DK0845005T3 - TRAF-inhibitorer - Google Patents

TRAF-inhibitorer

Info

Publication number
DK0845005T3
DK0845005T3 DK96927409T DK96927409T DK0845005T3 DK 0845005 T3 DK0845005 T3 DK 0845005T3 DK 96927409 T DK96927409 T DK 96927409T DK 96927409 T DK96927409 T DK 96927409T DK 0845005 T3 DK0845005 T3 DK 0845005T3
Authority
DK
Denmark
Prior art keywords
traf
inhibitors
trafs
pharmaceuticals
nucleic acid
Prior art date
Application number
DK96927409T
Other languages
Danish (da)
English (en)
Inventor
Mike Rothe
David V Goeddel
Original Assignee
Genentech Inc
Tularik Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genentech Inc, Tularik Inc filed Critical Genentech Inc
Application granted granted Critical
Publication of DK0845005T3 publication Critical patent/DK0845005T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
    • C07K14/7151—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons for tumor necrosis factor [TNF], for lymphotoxin [LT]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C07K14/4703—Inhibitors; Suppressors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Polymers With Sulfur, Phosphorus Or Metals In The Main Chain (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK96927409T 1995-08-17 1996-08-14 TRAF-inhibitorer DK0845005T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US238295P 1995-08-17 1995-08-17
PCT/US1996/013129 WO1997007134A1 (en) 1995-08-17 1996-08-14 Traf inhibitors

Publications (1)

Publication Number Publication Date
DK0845005T3 true DK0845005T3 (da) 2005-08-01

Family

ID=21700513

Family Applications (1)

Application Number Title Priority Date Filing Date
DK96927409T DK0845005T3 (da) 1995-08-17 1996-08-14 TRAF-inhibitorer

Country Status (13)

Country Link
US (6) US5789550A (de)
EP (2) EP1568708A3 (de)
JP (2) JP4382878B2 (de)
AT (1) ATE291585T1 (de)
AU (1) AU709535B2 (de)
CA (1) CA2227174A1 (de)
DE (1) DE69634512T2 (de)
DK (1) DK0845005T3 (de)
ES (1) ES2239334T3 (de)
IL (1) IL122980A0 (de)
NZ (1) NZ315514A (de)
WO (1) WO1997007134A1 (de)
ZA (1) ZA966663B (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA966663B (en) * 1995-08-17 1998-02-06 Genentech Inc Traf Inhibitors.
EP2003203A1 (de) 1996-12-23 2008-12-17 Immunex Corporation Ligand für den Rezeptorauslöser von NF-kappa b, wobei der Ligand Mitglied der TNF-Überfamilie ist
US6271349B1 (en) 1996-12-23 2001-08-07 Immunex Corporation Receptor activator of NF-κB
US6723517B1 (en) * 1998-06-02 2004-04-20 Minerva Biotechnologies Corporation Use of self-assembled monolayers to probe the structure of a target molecule
AU4567299A (en) * 1998-06-22 2000-01-10 Feshchenko, Elena A. C-cbl suppression of neoplastic transformation
CA2385879A1 (en) * 1999-09-23 2001-03-29 Rigel Pharmaceuticals, Inc. Traf4 associated cell cycle proteins, compositions and methods of use
WO2002064786A1 (fr) * 2001-02-15 2002-08-22 Mochida Pharmaceutical Co., Ltd. Nouveau gene tcif
US20050100547A1 (en) * 2001-06-07 2005-05-12 Pu Xia Etal Sphingosine kinase interacts with traf2 and modulates tumor necrosis factor-induced cellular activity
MY143582A (en) 2001-06-26 2011-05-31 Amgent Fremont Inc Antibodies to opgl
US20030083304A1 (en) * 2001-10-09 2003-05-01 Smart Robert C. CCAAT/enhancer binding protein-beta (C/EBPbeta) is a molecular target for cancer treatment
IL145918A0 (en) * 2001-10-14 2002-07-25 Ares Trading Sa Method and kit for monitoring recruitment of proteins to the intracellular domain of a receptor in intact cells
CA2494276A1 (en) * 2002-08-01 2004-02-12 Wyeth Methods and reagents relating to inflammation and apoptosis
MX2009010946A (es) * 2007-04-11 2009-10-29 Alcon Res Ltd Uso de un inhibidor del factor de necrosis tumoral alfa mas una antihistamina para tratar rinitis alergica y conjuntivitis alergica.
US20090182035A1 (en) * 2007-04-11 2009-07-16 Alcon Research, Ltd. Use of a combination of olopatadine and cilomilast to treat non-infectious rhinitis and allergic conjunctivitis
US12319726B2 (en) 2008-05-19 2025-06-03 Case Western Reserve University Method for treating CD40-mediated diseases
WO2009143141A1 (en) * 2008-05-19 2009-11-26 Case Western Reserve University Method for treating cd40-mediated diseases
US10669345B2 (en) * 2008-05-19 2020-06-02 Case Western Reserve University Method for treating CD40-mediated diseases
RU2011134857A (ru) 2009-01-21 2013-02-27 Вертекс Фармасьютикалз Инкорпорейтед Способы амплификации нуклеиновых кислот вируса гепатита с
KR20120091037A (ko) * 2009-10-01 2012-08-17 알콘 리서치, 리미티드 올로파타딘 조성물 및 그의 용도
US12522633B2 (en) 2020-04-02 2026-01-13 Case Western Reserve University Compositions and methods for treating CD40-mediated diseases

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3613167A1 (de) * 1986-04-18 1987-10-29 Basf Ag Verwendung von tnf zur herstellung von arzneimitteln
US5108901A (en) 1988-09-02 1992-04-28 Genentech, Inc. Tissue plasminogen activator having zymogenic or fibrin specific properties
US5395760A (en) * 1989-09-05 1995-03-07 Immunex Corporation DNA encoding tumor necrosis factor-α and -β receptors
DE10399023I2 (de) * 1989-09-12 2006-11-23 Ahp Mfg B V TFN-bindende Proteine
US5318890A (en) 1991-05-06 1994-06-07 The Regents Of The University Of California Assays for inhibitors of leukocyte adhesion
JPH10512443A (ja) * 1994-12-30 1998-12-02 ブリガム アンド ウイメンズ ホスピタル Ｔｒａｆ−媒介シグナルの制御
ZA966663B (en) * 1995-08-17 1998-02-06 Genentech Inc Traf Inhibitors.

Also Published As

Publication number Publication date
JP4382878B2 (ja) 2009-12-16
JP2009065981A (ja) 2009-04-02
NZ315514A (en) 1998-12-23
WO1997007134A1 (en) 1997-02-27
JPH11511967A (ja) 1999-10-19
EP0845005A1 (de) 1998-06-03
DE69634512T2 (de) 2006-02-09
EP0845005B1 (de) 2005-03-23
IL122980A0 (en) 1998-08-16
US20040087774A1 (en) 2004-05-06
EP1568708A3 (de) 2005-10-12
US6004553A (en) 1999-12-21
AU6723796A (en) 1997-03-12
CA2227174A1 (en) 1997-02-27
ES2239334T3 (es) 2005-09-16
US6060303A (en) 2000-05-09
ATE291585T1 (de) 2005-04-15
DE69634512D1 (de) 2005-04-28
ZA966663B (en) 1998-02-06
AU709535B2 (en) 1999-09-02
US6294348B1 (en) 2001-09-25
US6063585A (en) 2000-05-16
MX9800995A (es) 1998-10-31
EP1568708A2 (de) 2005-08-31
US5789550A (en) 1998-08-04

Similar Documents

Publication Publication Date Title
DK0845005T3 (da) TRAF-inhibitorer
NO961115D0 (no) Humane metabotrope glutamatreseptorsubtyper (HMR4, HMR6, HMR7) og relaterte DNA forbindelser
DK0724588T3 (da) Lægemiddelbindende protein
NO960767D0 (no) Protocadherinproteiner og deres anvendelse
CY1112101T1 (el) Νευροτροφικοι παραγοντες
NO985848L (no) Nytt protein og fremgangsmÕte for fremstilling av dette
DK0811063T3 (da) Kemokin-receptor 88C og dens antistoffer
FI962247A7 (fi) Uudet apoptoosia muuntavat proteiinit, niitä koodaava DNA ja näiden kä yttömenetelmät
DE69833014D1 (de) Menschliche toll homologen
DE69535274D1 (de) Verwendung eines menschlichen interleukin-11 rezeptors
ATE342976T1 (de) Cytokinrezeptor-kette
DK0901526T3 (da) Cortistatin: neuropeptider, sammensætninger og metoder
DE69728897D1 (de) Saeugetierchemokine
ATE171217T1 (de) Methoden zur synthese und reinigung von peptiden
NO20005819L (no) Nye peptidfragmenter for rensing av proteiner
WO2001021794A3 (en) Smad associating polypeptides
RU94026276A (ru) Рецепторы интерлейкина-12 и антител